SENSITIVITY TO CONVENTIONAL CHEMOTHERAPEUTIC DRUGS ACCORDING TO ARID1A DEFICIENCY OF OVARIAN CLEAR CELL CARCINOMA AND ENDOMETRIOID CARCINOMA CELLS

被引：0
|
作者：
Kuroda, T. [1 ,2 ]
Ogiwara, H. [1 ]
Takahashi, K. [1 ,2 ]
Sasaki, M. [1 ]
Yoshida, H. [3 ]
Kato, T. [4 ]
Okamoto, A. [2 ]
Kohno, T. [1 ]
机构：
[1] Natl Canc Ctr, Div Genome Biol, Res Inst, Tokyo, Japan
[2] Jikei Univ, Dept Obstet & Gynecol, Sch Med, Tokyo, Japan
[3] Natl Canc Ctr, Dept Pathol & Clin Labs, Tokyo, Japan
[4] Natl Canc Ctr, Dept Gynecol, Tokyo, Japan
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2018年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IGCS8-0330
引用
收藏
页码：180 / 180
页数：1
相关论文
共 50 条
  • [41] Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma
    Katagiri, Atsuko
    Nakayama, Kentaro
    Rahman, Mohammed Tanjimur
    Rahman, Munmun
    Katagiri, Hiroshi
    Nakayama, Naomi
    Ishikawa, Masako
    Ishibashi, Tomoka
    Iida, Kouji
    Kobayashi, Hiroshi
    Otsuki, Yoshiro
    Nakayama, Satoru
    Miyazaki, Kohji
    MODERN PATHOLOGY, 2012, 25 (02) : 282 - 288
  • [42] Clinicopathological correlation of ARID1A status with HDAC6 and its related factors in ovarian clear cell carcinoma
    Yano, Mitsutake
    Katoh, Tomomi
    Miyazawa, Mariko
    Miyazawa, Masaki
    Ogane, Naoki
    Miwa, Maiko
    Hasegawa, Kosei
    Narahara, Hisashi
    Yasuda, Masanori
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [43] Clinicopathological correlation of ARID1A status with HDAC6 and its related factors in ovarian clear cell carcinoma
    Mitsutake Yano
    Tomomi Katoh
    Mariko Miyazawa
    Masaki Miyazawa
    Naoki Ogane
    Maiko Miwa
    Kosei Hasegawa
    Hisashi Narahara
    Masanori Yasuda
    Scientific Reports, 9
  • [44] Clinicopathological correlation of ARID1A status with HDAC6 and its related factors in ovarian clear cell carcinoma
    Yano, Mitsutake
    Katoh, Tomomi
    Miyazawa, Mariko
    Miyazawa, Masaki
    Ogane, Naoki
    Miwa, Maiko
    Hasegawa, Kosei
    Narahara, Hisashi
    Yasuda, Masanori
    MODERN PATHOLOGY, 2019, 32
  • [45] Clinicopathological correlation of ARID1A status with HDAC6 and its related factors in ovarian clear cell carcinoma
    Yano, Mitsutake
    Katoh, Tomomi
    Miyazawa, Mariko
    Miyazawa, Masaki
    Ogane, Naoki
    Miwa, Maiko
    Hasegawa, Kosei
    Narahara, Hisashi
    Yasuda, Masanori
    LABORATORY INVESTIGATION, 2019, 99
  • [46] Biomolecular features of ARID1A, HNF1β and ERα in clear cell carcinoma of the ovary
    Abou-Taleb, H.
    Yamaguchi, K.
    Mandai, M.
    Amano, Y.
    Kosaka, K.
    Matsumura, N.
    Baba, T.
    Yoshioka, Y.
    Hamanishi, J.
    Konishi, I
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2012, 119 : 159 - 160
  • [47] Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study
    Zhou, Ling
    Yao, Liqing
    Dai, Lin
    Zhu, Honglan
    Ye, Xue
    Wang, Shang
    Cheng, Hongyan
    Ma, Ruiqiong
    Liu, Huiping
    Cui, Heng
    Chang, Xiaohong
    JOURNAL OF OVARIAN RESEARCH, 2021, 14 (01)
  • [48] Magnetic resonance imaging for differentiating ovarian endometrioid carcinoma from clear cell carcinoma
    Kim, K. A.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 334 - 335
  • [49] Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study
    Ling Zhou
    Liqing Yao
    Lin Dai
    Honglan Zhu
    Xue Ye
    Shang Wang
    Hongyan Cheng
    Ruiqiong Ma
    Huiping Liu
    Heng Cui
    Xiaohong Chang
    Journal of Ovarian Research, 14
  • [50] ARID1A mutation/ARID1A loss is associated with a high immunogenic profile in clear cell ovarian cancer
    Kuroda, Yuka
    Chiyoda, Tatsuyuki
    Kawaida, Miho
    Nakamura, Kohei
    Aimono, Eriko
    Yoshimura, Takuma
    Takahashi, Mio
    Saotome, Keiko
    Yoshihama, Tomoko
    Iwasa, Naomi
    Sakai, Kensuke
    Yamagami, Wataru
    Nishihara, Hiroshi
    Aoki, Daisuke
    GYNECOLOGIC ONCOLOGY, 2021, 162 (03) : 679 - 685
12345